Presentation is loading. Please wait.

Presentation is loading. Please wait.

287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme  Harold T.

Similar presentations


Presentation on theme: "287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme  Harold T."— Presentation transcript:

1 287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme  Harold T. Spencer, Larisa Pereboeva, George Y. Gillespie, Anindya Dasgupta, Kathryn S. Sutton, Lawrence S. Lamb  Molecular Therapy  Volume 23, (May 2015) DOI: /S (16) Copyright © 2015 The American Society of Gene & Cell Therapy Terms and Conditions

2 Molecular Therapy 2015 23, DOI: (10.1016/S1525-0016(16)33896-5)
Copyright © 2015 The American Society of Gene & Cell Therapy Terms and Conditions

3 Molecular Therapy 2015 23, DOI: (10.1016/S1525-0016(16)33896-5)
Copyright © 2015 The American Society of Gene & Cell Therapy Terms and Conditions


Download ppt "287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme  Harold T."

Similar presentations


Ads by Google